| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/19/2008 | CN101143199A Traditional Chinese medicine for treating chronic bronchitis |
| 03/19/2008 | CN101143197A Bone infarction granule |
| 03/19/2008 | CN101143195A Traditional Chinese medicine for treating pulmonary tuberculosis and sequela |
| 03/19/2008 | CN101143194A Traditional Chinese medicine for treating interstitial pneumonia |
| 03/19/2008 | CN101143188A Traditional Chinese medicine for treating chronic asthma type brochitis |
| 03/19/2008 | CN101143176A Traditional Chinese medicine for treating lung cancer |
| 03/19/2008 | CN101143126A Ethyl cellulose slow release system for nucleophilic NO donor medicine and its preparation method |
| 03/19/2008 | CN101143025A Mixed type liquid cigarette and its preparation technique and application |
| 03/19/2008 | CN101143004A Moxa leaf rice paste and its making method |
| 03/19/2008 | CN100375609C Dripping pills of emblic leafflower fruit and its preparation process |
| 03/18/2008 | US7345138 Biodegradable polyphosphates for controlled release of bioactive substances |
| 03/18/2008 | US7345063 Amides, preparation and therapeutic use as modulators of CCR-receptor activity |
| 03/18/2008 | US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | US7345041 Chemical compounds |
| 03/18/2008 | US7345037 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase |
| 03/18/2008 | US7345023 Treatment of hyperproliferative conditions of body surfaces |
| 03/18/2008 | CA2401005C Methods for extraction and reaction using supercritical fluids |
| 03/18/2008 | CA2394120C Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it |
| 03/18/2008 | CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/18/2008 | CA2219659C Rapamycin derivatives |
| 03/13/2008 | WO2008031048A2 Enhanced mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| 03/13/2008 | WO2008031028A2 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| 03/13/2008 | WO2008030887A2 Methods for designing parp inhibitors and uses thereof |
| 03/13/2008 | WO2008030158A1 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
| 03/13/2008 | WO2008029924A1 Cyclic aminoalkylcarboxamide derivative |
| 03/13/2008 | WO2008029882A1 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient |
| 03/13/2008 | WO2008029829A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2008029493A1 Nerve fiber degeneration inhibitor |
| 03/13/2008 | WO2008029169A2 Method of treating respiratory disorders |
| 03/13/2008 | WO2008028935A2 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
| 03/13/2008 | WO2008028324A1 Novel levamisole formulation for allergic rhinitis |
| 03/13/2008 | WO2008012290A3 Quinuclidine derivatives as m3 antagonists |
| 03/13/2008 | WO2008003701A3 Combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases |
| 03/13/2008 | US20080064746 Lipoxins and Aspirin-Triggered Lipoxins and Their Stable Analogs in the Treatment of Asthma and Inflammatory Airway Diseases |
| 03/13/2008 | US20080064731 Remedy for chronic disease |
| 03/13/2008 | US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate |
| 03/13/2008 | US20080064710 Novel Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064668 Carbon 20 is substituted with methyl or cyclopropyl, carbon 16 is a single or double bond, and carbon 23 is a single, double, or triple bond; side effect reduction; vitamin deficiency; anticarcinogenic antiarthritic agents; immunotherapy; metabolic disorders; gene expression inhibition of ILT3 |
| 03/13/2008 | US20080064650 Therapeutic uses of inhibitors of RTP801L |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080064096 Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 03/13/2008 | US20080063734 Schisandra extract; Ginseng extract; Radix ophiopogonis extract; and Salvia miltiorrhiza extract; water extraction, alcohol extraction; Scientifically Concentrated Traditional Chinese Medicine |
| 03/13/2008 | US20080063606 Pulmonary delivery of aminoglycoside |
| 03/13/2008 | US20080060645 Dry Powder Inhalant Composition |
| 03/13/2008 | CA2662732A1 Use of a pharmaceutical composition comprising an anticholinergic for killing microorganisms and for treating respiratory tract infections |
| 03/13/2008 | CA2662716A1 Method of treating respiratory disorders |
| 03/13/2008 | CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators |
| 03/13/2008 | CA2661992A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897870A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 03/12/2008 | EP1896473A1 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 03/12/2008 | EP1896450A1 2-substituted benzimidazoles |
| 03/12/2008 | EP1896449A1 Heterocyclylaminoalkyl substituted benzimidazoles |
| 03/12/2008 | EP1896427A2 Novel 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 03/12/2008 | EP1896418A1 Quinoline 3 -sulfonate esters as nk3 receptor modulators |
| 03/12/2008 | EP1896416A1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 03/12/2008 | EP1896059A2 Airway administration of tissue factor pathway inhibitor in inflammatory conditons affecting the respiratory tract |
| 03/12/2008 | EP1896053A1 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use |
| 03/12/2008 | EP1896026A2 Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof |
| 03/12/2008 | EP1896022A1 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion |
| 03/12/2008 | EP1697345B1 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | EP1495009B1 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 03/12/2008 | EP1450775B1 C-kit inhibitors for treating bacterial infections |
| 03/12/2008 | CN101142219A Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof |
| 03/12/2008 | CN101142218A Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 03/12/2008 | CN101142208A 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication |
| 03/12/2008 | CN101142189A 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 03/12/2008 | CN101142188A 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 03/12/2008 | CN101142185A Indoles useful in the treatment of inflammation |
| 03/12/2008 | CN101141956A Use of CRTH2 antagonist compounds in therapy |
| 03/12/2008 | CN101139343A Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
| 03/12/2008 | CN101138628A Chinese medicine for treating common cold in any season |
| 03/12/2008 | CN101138627A Chinese medicine for treating cough aphonia |
| 03/12/2008 | CN101138620A Chinese medicine for treating itching throat and dry cough |
| 03/12/2008 | CN101138619A Chinese medicine for treating endless cough |
| 03/12/2008 | CN101138613A Chinese traditional medicine for treating acute bronchitis of children |
| 03/12/2008 | CN101138605A Chinese medicine for treating summer heat-dampness rheum |
| 03/12/2008 | CN101138604A Chinese medicine for treating intractable cough |
| 03/12/2008 | CN101138599A Smoking toxin-expelling phlegm-eliminating Chinese traditional medicine powder dip |
| 03/12/2008 | CN101138595A Prescription of health radix rehmanniae lozenge |
| 03/12/2008 | CN101138591A Chinese medicine for treating exogenous cough |
| 03/12/2008 | CN101138584A Chinese medicine for treating acute bronchitis chronic cough |
| 03/12/2008 | CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds |
| 03/12/2008 | CN101138551A Preparation method of lung targeting emodin polylactic acid microsphere and application in anti-mouse pulmonary fibrosis |
| 03/12/2008 | CN100374464C Anti-SARS monoclonal antibody, encoding sequence and application thereof |
| 03/12/2008 | CN100374454C preparation method of 2-aminocarbonyl-9h-purine derivatives and intermediate thereof |
| 03/12/2008 | CN100374229C Deoxidation casting, aluminium casting and casting equipment |
| 03/12/2008 | CN100374114C Antibiotic compositions for treatment of the eye, ear and nose |
| 03/12/2008 | CN100374105C Glabrous sarcandra herb lyophilized powder for injection, its high-dose injection and preparing method |
| 03/12/2008 | CN100374104C Scutellaria alkyl amine granules and its preparation method |
| 03/11/2008 | US7342125 Administering derivatives of Kauranoic acid; cachexia, analgesics, in treating immune disorders, as anti-cancer and anti-tumor agents, otitis media, sinusitis, antidiabetic agent |
| 03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
| 03/11/2008 | US7342029 Substituted indoles |
| 03/11/2008 | US7342006 Substituted 8-heteroaryl xanthines |